Renal Function Test Market

Renal Function Test Market Outlook 2023 to 2033

The global market revenue for the renal function test market is anticipated to reach USD 1,494.1 million by 2033, with a 5.5% CAGR during the forecast period. As of 2023, the renal function test market is valued at USD 871.3 million.

Key Market Highlights

Growing Prevalence of Diabetes and Hypertension Boosts Renal Function Test Market

Renal function test refers to a series of blood and urine tests that help doctors understand the condition of patients' kidneys. In these few decades, cardiovascular disease has tremendously increased due to a passive lifestyle, alcohol abuse, and unhealthy eating habits. These diseases are the leading causes of chronic kidney diseases, which require regular monitoring of kidney functions, which is done by renal function tests.

According to the World Health Organization, around 422 million people worldwide have diabetes, and more than one billion people suffer from problems related to hypertension. As these numbers continue and are expected to grow, a rising demand for renal function tests can be seen in the upcoming years.

Digital Urinalysis at Home to Contribute Significantly to Kidney Assessment Tests

Advancements in renal function test technologies have enabled patients suffering from chronic kidney disease (CKD) to take regular tests at home. This technology may simplify the process and drive more revenue globally for the renal function test market.

Patients can now cut long lines and hefty consultation fees in public hospitals. The test results can even be accessed by the concerned medical practitioner, who can assess and proceed further with the treatment.

Attributes	Key Statistics
Expected Base Year Value (2023)	USD 871.3 million
Anticipated Forecast Value (2033)	USD 1,494.1 million
Estimated Growth (2023 to 2033)	5.5% CAGR

Historical Comparison of the Renal Function Test Market with the Forecast Period

The market recorded a growth of 5.7% from 2017 to 2022 due to the increased risk of kidney diseases among the aging population. The market registered a valuation of USD 623.6 million in 2017 and reached USD 824.2 million in 2022.

Attributes	Key Statistics
Expected Base Year Value (2017)	USD 623.6 million
Anticipated Forecast Value (2022)	USD 842.2 million
Estimated Growth (2017 to 2022)	5.7% CAGR

When it comes to age, older people are more likely to undergo renal function tests as they require frequent testing due to the increased risk of kidney diseases. There are relatively few cases of kidney assessments being done on newborn babies and young children.

Availability and accessibility are crucial in the renal function test market. Areas with medium to low medical facilities showcase have very little influence on the market, while regions with highly advanced medical facilities are likely to have higher consumption rates of renal function tests. These factors led to the growth of RFT in the historical period.

Gender-wise, it has been observed that males contribute significantly to the renal function test market, mainly due to their association with an unhealthy lifestyle. Moreover, the growth of telemedicine services like digital urinalysis has increased awareness regarding preventive health care measures. Thus, the demand for renal function tests has surged remarkably.

Factors Driving the Expansion of the Renal Function Test Market

• Soaring CKD cases: Chronic kidney diseases (CKD) have been the key root cause of kidney disorders, including complete kidney failure. As more people are at risk of kidney problems, the demand for renal function tests is also growing.
• Aging Population: The aging population in countries with a very high-density population is always under the radar of chronic kidney diseases. These individuals require intense care and regular assessment of their kidney functionalities, leading to a higher demand for renal function tests.
• Technological Advancements: Continuous scientific breakthroughs in medical technology have led to simpler, faster, and more accurate renal function test results. This eventually resulted in more people trusting the test results, expanding the global market size.
• Personal Care: Due to a better understanding of personal health care and necessary preventive measures, a large chunk of the global population undergoes regular body check-ups, which include renal function tests.
• Health Care Programs: Recent years have seen a notable rise in health initiatives both in the public and private sectors. Medical camps, which include full body check-ups, are being conducted regularly. Government-sponsored medical camps also have decent participation in the growth of the renal function test market.

Factors Adversely Affecting the Renal Function Test Market

• Expensive Costs: Renal function tests can be expensive if not covered by insurance. As these tests must be done regularly, patients with low-income sources may need help to afford testing costs. Although, these prices could be higher in government-aided hospitals, long waiting lines and lower reliability of the results are some main reasons people are reluctant to visit these facilities for renal function tests.
• Lack of Awareness: There needs to be more awareness regarding kidney health and the significance of the same. Limited health literacy in underdeveloped regions of the world can be a key factor in the negligence of renal health and, thus, renal function tests.
• Asymptomatic Nature: Most kidney diseases can be asymptomatic in their initial stages. Without visible symptoms, there are very few chances that individuals may consider choosing renal function tests. This can result in delayed or missed opportunities to detect CKDs while they can be easily diagnosed.
• Government Negligence: Government policies are very detrimental in promoting preventive health care programs. Inadequate emphasis on diseases related to kidneys is one of the main reasons for the need for more awareness regarding renal function tests.
• Insurance Coverage: Individuals may be deterred from seeking testing if they have to bear the costs of it regularly. Even individuals with insurance coverage may refrain from taking regular tests due to the non-inclusion of renal function tests. This may affect the renal function test market in the long term.

Category-wise Outlook

Urinalysis for Kidney Function Using Dipsticks Continues to be Essential for Renal Health Care

Category-wise, the renal function test market is divided into dipsticks, disposables, and reagents. The dipstick renal function test, which dominates the segment with a revenue share of 57.4%, is a simple and very commonly used renal test to monitor kidney functions. It is the most commonly used renal test and is considered to provide quick results, sometimes within minutes after the test.

Attributes	Details
By Product Type	Dipsticks
Market share	57.4%

While renal function tests are often regarded as cost-intensive, urinalysis using dipsticks is generally more affordable and more accessible to the general population. These tests are very simple, making them very reassuring for patients who avoid long medical procedures. The infrastructure requirements for dipstick renal function tests are minimal and can be set up with a meager investment.

A renal function test using a dipstick can be the first step in assessing the overall functionality of the kidneys. Apart from kidneys, they also provide very brief information about urinal health and the amount of certain essential nutrients in the blood. Although dipstick renal tests help medical practitioners understand the overall renal information, the results are only nominal and not very precise.

Medical Practitioners Show a Lot of Reliability in Urine-based Renal Tests

Urine-based renal examinations are the most common practice used by the majority of laboratories, as they are trusted to be the most reliable test to assess urinal health. It holds a global market share of 62.4% and is found to provide quick results at affordable prices.

Attributes	Details
By Test Type	Urine
Market share	62.4%

These tests are recommended as a regular practice and are not just limited to renal health but also consist of the functionality of the urinary tract, kidneys, and other excretory organs. Urine-based tests don't require drawing blood from the patient's body parts, making this a preferable choice for individuals intimidated by syringes and blood.

It's the easiest way to collect samples; patients can do that alone. Urine-based tests can be easily incorporated into routine check-ups. The ease of sample collection, simple setup, and broad spectrum of information can help urine-based renal tests gain impetus in the upcoming years.

Hospitals are a Preferred Destination for Renal Function Tests

The renal function test market is segmented by end-use into hospitals and clinics, diagnostic laboratories, research laboratories and institutes, and home care settings. As hospitals provide more holistic care in terms of renal tests, they dominate this segment by holding a global market share of 50.6%.

Attributes	Details
By End User	Hospitals and Clinics
Market share	50.6%

Hospitals are packed with modern medical facilities and skilled lab technicians who can conduct simultaneous tests in the same vicinity. This makes conducting complex medicinal examinations like renal function tests very feasible. Hospitals can also provide in-house treatment facilities for patients requiring inpatient care and monitoring.

Region-wise Outlook

North America Showcases Significant Cases of Renal Disorders in 2022

Passive urban lifestyles with little to no exercise, alcohol abuse, and unhealthy eating habits contribute to kidney dysfunction. According to a survey conducted by Future Market Insights, the North American renal function testing market recorded a market share of 34.3% in 2022.

Region	North America
Value Share in 2022	34.3%

As one in three individuals living in this belt has diabetes, the possibility of them getting diagnosed with CKD is very high. As individuals with chronic kidney disorders require intense care and monitoring of their renal health, the demand for such facilities is touching the skies in this region.

The European Region Becomes the Topmost Contributor to the Global Renal Function Test Market

Technological advancements in the medical facilities of several European countries have largely contributed to the growth of the global renal function market. Of the total market, Europe holds a market share of 29.8%.

Region	Europe
Value Share in 2022	29.8%

Government initiatives coupled with health-literate residents are some of the main factors in this promising market size. For instance, Atlas Medical, a diagnostic kit manufacturer based in the United Kingdom, introduced products in blood grouping reagents, urine reagent strips, latex kits, and other home test kits.

Country-wise Insights

Kidney Diseases Becomes the Leading Cause of Death in the United States

According to the Centers for Disease Control, more than 37 million citizens of the United States have chronic kidney disorders; it is estimated that 90% of them don't even know they have it. The government bodies' CKD Initiative is shaped to collaborate with the leading hospitals, colleges, and national organizations to promote early diagnosis and reduce the risk factors by detecting the symptoms in the initial stages of the disorder.

Country	The United States
Value Share in 2022	28.8%

Growing Population in China Fuel Renal Function Test Market Expansion

The increasing geriatric population coupled with highly affluent residents makes China one of the most influential markets in renal function tests. As a country with a huge population, the demand for renal function tests may drastically boost the market size. Like most developed countries, the Chinese government has made huge investments in the research and promotion of CKDs.

Country	China
Value Share in 2022	7.4%

Competitive Landscape in Renal Function Test Market

Many start-up and established companies are bringing innovative medical devices that can ease the process of urine and blood tests to check the health of kidneys.

Several visionaries are at the forefront of delivering accurate results while maintaining transparency. F. Hoffmann-La Roche Ltd., Nova Biomedical, Quest Diagnostics, and ACON Laboratories are some business leaders dominating the renal function test market.

Recent Developments in the Renal Function Test Market

• In June 2023, Boditech Med and SphingoTec signed a market development agreement regarding further developing their flagship kidney function biomarker, penKid. penKid is a medical technology that provides precise renal information in renal replacement therapies.
• In August 2022, Bloom Diagnostics, a Swiss medtech company, launched a new test designed to rapidly measure and quantify kidney function in users 18 years of age and older.
• In June 2023, IDEXX Laboratories launched its first-of-a-kind renal function test for pet animals such as cats and dogs. This new technology can be a boon for veterinary professionals to detect renal abnormalities in their initial stages.

Key Companies in the Market

• F. Hoffmann-La Roche Ltd.
• Siemens Healthineers
• Beckman Coulter (Danaher)
• Abbott Laboratories Baxter International
• Quest Diagnostic Incorporated
• Sysmex Corporation
• Laboratory Corporation of America Holdings (LabCorp)
• Randox Laboratories
• ACON Laboratories
• Arkray
• Nova Biomedical
• Idexx Laboratories
• Opti Medicals
• Elektronika
• Cook Medical
• VedaLab
• Dx Gern Corp

Key Segments Covered in Renal Function Test Market Report

By Product Type:

• Dipsticks
• Disposable
• Reagents

By Test Type:

• Urine
• Blood Test

By End User:

• Hospitals and Clinics Diagnostic laboratories
• Research Laboratories and Institutes
• Home Care Settings

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• The Middle East and Africa (MEA)

Frequently Asked Questions

How Big is the Renal Function Test Market?

The current market valuation of renal function tests is likely to be USD 871.3 million.

Which Region is Forecast to be Lucrative for Renal Function Test Market?

North America is expected to accumulate 34.3% of the market share in 2022.

What is the Market Potential for Renal Function Tests by 2033?

The renal function test market is expected to reach USD 1,494.1 million

Which Test Type is Widely Preferred in the Market?

Urine-based renal tests are the widely preferred segment.

How was the Historical Performance of the Market?

The market recorded a valuation of USD 824.2 million in 2022.